RYAPURTECH is focused on the manufacturing and validation of Immunoglobulin Y (IgY) to tackle infectious diseases. Additional interests include the design of cost-effective production and purification platforms for other biopharmaceuticals, proteins, and enzymes, as well as the identification of alternative and effective stabilizers for these biological products. RYAPURTECH owns the IP rights of a cost-effective purification platform to produce high-quality and high-purity IgY antibodies. The high yield and purity degree of the obtained IgY antibodies allow their intravenous administration.RYAPURTECH has extensive know-how to design novel cost-effective purification platforms and alternative stabilizers for a wide range of biopharmaceuticals, proteins, and enzymes. RYAPURTECH has equipped labs and the required conditions to work in the bioprocessing field.